These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 9878184)

  • 1. Suppression of experimental autoimmune encephalomyelitis by tyrphostin AG-556.
    Brenner T; Poradosu E; Soffer D; Sicsic C; Gazit A; Levitzki A
    Exp Neurol; 1998 Dec; 154(2):489-98. PubMed ID: 9878184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Essential role for ERK mitogen-activated protein kinase in matrix metalloproteinase-9 regulation in rat cortical astrocytes.
    Arai K; Lee SR; Lo EH
    Glia; 2003 Sep; 43(3):254-64. PubMed ID: 12898704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of p38 mitogen-activated protein kinase and extracellular signal-regulated protein kinase kinase in adenosine A2B receptor-mediated interleukin-8 production in human mast cells.
    Feoktistov I; Goldstein AE; Biaggioni I
    Mol Pharmacol; 1999 Apr; 55(4):726-34. PubMed ID: 10101031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of protein kinase C isoforms protects RAW 264.7 macrophages from nitric oxide-induced apoptosis: involvement of c-Jun N-terminal kinase/stress-activated protein kinase, p38 kinase, and CPP-32 protease pathways.
    Jun CD; Oh CD; Kwak HJ; Pae HO; Yoo JC; Choi BM; Chun JS; Park RK; Chung HT
    J Immunol; 1999 Mar; 162(6):3395-401. PubMed ID: 10092794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of the JNK/SAPK signal transduction pathway in the induction of iNOS by TNF-alpha.
    Chan ED; Riches DW
    Biochem Biophys Res Commun; 1998 Dec; 253(3):790-6. PubMed ID: 9918806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanical endothelial damage results in basic fibroblast growth factor-mediated activation of extracellular signal-regulated kinases.
    Pintucci G; Steinberg BM; Seghezzi G; Yun J; Apazidis A; Baumann FG; Grossi EA; Colvin SB; Mignatti P; Galloway AC
    Surgery; 1999 Aug; 126(2):422-7. PubMed ID: 10455916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A low molecular weight copper chelator crosses the blood-brain barrier and attenuates experimental autoimmune encephalomyelitis.
    Offen D; Gilgun-Sherki Y; Barhum Y; Benhar M; Grinberg L; Reich R; Melamed E; Atlas D
    J Neurochem; 2004 Jun; 89(5):1241-51. PubMed ID: 15147517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential activation of c-Jun NH2-terminal kinase and p38 mitogen-activated protein kinases by methyl methanesulfonate in the liver and brain of rats: implication for organ-specific carcinogenesis.
    Suh Y; Kang UG; Kim YS; Kim WH; Park SC; Park JB
    Cancer Res; 2000 Sep; 60(18):5067-73. PubMed ID: 11016630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of experimental autoimmune encephalomyelitis by a tyrosine kinase inhibitor.
    Constantin G; Laudanna C; Brocke S; Butcher EC
    J Immunol; 1999 Jan; 162(2):1144-9. PubMed ID: 9916745
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of nitric oxide synthase for treatment of experimental autoimmune encephalomyelitis.
    Brenner T; Brocke S; Szafer F; Sobel RA; Parkinson JF; Perez DH; Steinman L
    J Immunol; 1997 Mar; 158(6):2940-6. PubMed ID: 9058833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide and pneumococcal cell wall components activate the mitogen activated protein kinases (MAPK) erk-1, erk-2, and p38 in astrocytes.
    Schumann RR; Pfeil D; Freyer D; Buerger W; Lamping N; Kirschning CJ; Goebel UB; Weber JR
    Glia; 1998 Mar; 22(3):295-305. PubMed ID: 9482215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites.
    López-Talavera JC; Levitzki A; Martínez M; Gazit A; Esteban R; Guardia J
    J Clin Invest; 1997 Aug; 100(3):664-70. PubMed ID: 9239414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of mitogen-activated protein kinases in experimental autoimmune encephalomyelitis.
    Shin T; Ahn M; Jung K; Heo S; Kim D; Jee Y; Lim YK; Yeo EJ
    J Neuroimmunol; 2003 Jul; 140(1-2):118-25. PubMed ID: 12864979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
    Colombo E; Di Dario M; Capitolo E; Chaabane L; Newcombe J; Martino G; Farina C
    Ann Neurol; 2014 Sep; 76(3):325-37. PubMed ID: 25043204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrphostin AG 556 improves survival and reduces multiorgan failure in canine Escherichia coli peritonitis.
    Sevransky JE; Shaked G; Novogrodsky A; Levitzki A; Gazit A; Hoffman A; Elin RJ; Quezado ZM; Freeman BD; Eichacker PQ; Danner RL; Banks SM; Bacher J; Thomas ML; Natanson C
    J Clin Invest; 1997 Apr; 99(8):1966-73. PubMed ID: 9109441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrphostin AG 555 inhibits bovine papillomavirus transcription by changing the ratio between E2 transactivator/repressor function.
    Baars S; Bachmann A; Levitzki A; Rösl F
    J Biol Chem; 2003 Sep; 278(39):37306-13. PubMed ID: 12867421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrphostin AG490, a tyrosine kinase inhibitor, blocks actively induced experimental autoimmune encephalomyelitis.
    Constantin G; Brocke S; Izikson A; Laudanna C; Butcher EC
    Eur J Immunol; 1998 Nov; 28(11):3523-9. PubMed ID: 9842895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide inhibits CXCL12 expression in neuroinflammation.
    Petković F; Blaževski J; Momčilović M; Mostarica Stojkovic M; Miljković D
    Immunol Cell Biol; 2013 Jul; 91(6):427-34. PubMed ID: 23732617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrphostin AG126 exerts neuroprotection in CNS inflammation by a dual mechanism.
    Menzfeld C; John M; van Rossum D; Regen T; Scheffel J; Janova H; Götz A; Ribes S; Nau R; Borisch A; Boutin P; Neumann K; Bremes V; Wienands J; Reichardt HM; Lühder F; Tischner D; Waetzig V; Herdegen T; Teismann P; Greig I; Müller M; Pukrop T; Mildner A; Kettenmann H; Brück W; Prinz M; Rotshenker S; Weber MS; Hanisch UK
    Glia; 2015 Jun; 63(6):1083-99. PubMed ID: 25731696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors.
    Novogrodsky A; Vanichkin A; Patya M; Gazit A; Osherov N; Levitzki A
    Science; 1994 May; 264(5163):1319-22. PubMed ID: 8191285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.